对于患有轻链氨基粉症的患者,无血清光链基于水平和非固定周期的达拉图穆马布治疗策略

Zhen Li1, Jinzhou Guo1, Wencui Chen1

  • 1National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Annals of medicine
|December 19, 2024
PubMed
概括

根据血清自由轻链 (sFLC) 水平和灵活的循环指导的达拉图穆马布 (DARA) 治疗在全身轻链 (AL) 氨基粉症患者中显示出高的疗效和安全性. 这种方法实现了出色的血液学反应率和有利的生存估计.